Cognito Therapeutics Inc

Cognito Therapeutics, Inc. develops biotechnology and medical device solutions for neurodegenerative diseases. The company conducts clinical research and feasibility studies for Alzheimer's treatment, advances sensory stimulation technology, and develops non-invasive neuroprotective therapies. Cognito Therapeutics serves patients with neurodegenerative diseases in the US.